Opko Sees Huge Long-Term Impact From Prolor Deal

Opko Sees Huge Long-Term Impact From Prolor Deal Play

Aug. 21 (Bloomberg) -- Phillip Frost, chief executive officer of Opko Health Inc., talks about its share listing on the Tel Aviv Stock Exchange today and the acquisition of Israeli drugmaker Prolor Biotech Inc. He speaks with Elliott Gotkine on Bloomberg Television's "On the Move." (Source: Bloomberg)

  • On Air Now

    Bloomberg West Watch Now

  • Next

    Charlie Rose

blog comments powered by Disqus